Skip to content

CNSP

CNS Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.73
−2.66%
Ask drillr
1
Insider buys (3m)
0
Insider sells (3m)
$10.0K
Net value (3m)
+16.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026Fisher Michal · directorPurchase2,000$5.00
Aug 18, 2026Levin Rami · officer: CEO and PresidentM-Exempt4,750$0.00
May 20, 2026Charles Faith L. · directorPurchase7,100$4.79
Mar 4, 2026Faulkner Eric · officer: Chief Technology OfficerA-Award9,500$0.00
Mar 4, 2026O'Loughlin Steve · officer: Chief Financial OfficerA-Award9,500$0.00
Jan 2, 2026Levin Rami · director, officer: CEO and PresidentA-Award19,000$0.00
Nov 19, 2025Charles Faith L. · directorA-Award1,517$12
Nov 19, 2025Downs Christopher · officer: Chief Financial OfficerA-Award4,881$30
Nov 19, 2025Gumulka Jerzy · directorA-Award1,517$12
Nov 19, 2025Keyes Jeffry R. · directorA-Award1,517$12
Nov 19, 2025Cockroft Bettina M. · directorA-Award1,517$12
Nov 19, 2025Climaco John M · director, officer: Chief Executive OfficerA-Award9,761$30
Nov 19, 2025Mahery Amy · directorA-Award1,517$12
Apr 10, 2024Cockroft Bettina M. · directorA-Award17,500$0.00
Apr 10, 2024Climaco John M · director, officer: Chief Executive OfficerA-Award83,000$0.00
Apr 10, 2024Charles Faith L. · directorA-Award17,500$0.00
Apr 10, 2024Mahery Amy · directorA-Award17,500$0.00
Apr 10, 2024Keyes Jeffry R. · directorA-Award17,500$0.00
Apr 10, 2024Gumulka Jerzy · directorA-Award17,500$0.00
Apr 10, 2024Evans Carl Anthony · directorA-Award17,500$0.00
Apr 10, 2024Downs Christopher · officer: Chief Financial OfficerA-Award40,000$0.00
Feb 6, 2024Gumulka Jerzy · directorA-Award33,333$0.30
Feb 6, 2024Mahery Amy · directorA-Award12,420$0.25
Feb 6, 2024Gumulka Jerzy · directorPurchase33,333$0.30
Feb 6, 2024Evans Carl Anthony · directorA-Award33,333$0.30
Feb 6, 2024Evans Carl Anthony · directorPurchase33,333$0.30
Feb 6, 2024Downs Christopher · officer: Chief Financial OfficerA-Award66,666$0.30
Feb 6, 2024Downs Christopher · officer: Chief Financial OfficerPurchase66,666$0.30
Feb 6, 2024Climaco John M · director, officer: Chief Executive OfficerA-Award166,666$0.30
Feb 6, 2024Climaco John M · director, officer: Chief Executive OfficerPurchase166,666$0.30
Institutional positioning

13F filings over the trailing two quarters

New 4Increased 2Reduced 0Sold out 11
FilerActionSharesFiled
STONEPINE CAPITAL MANAGEMENT, LLCIncreased61,000May 14, 2026
IKARIAN CAPITAL, LLCUnchanged45,830May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCNew Position23,189May 15, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged13,524May 15, 2026
TOWER RESEARCH CAPITAL LLC (TRC)New Position1,310May 15, 2026
UBS GROUP AGIncreased729May 5, 2026
BARRETT & COMPANY, INC.Unchanged8May 4, 2026
MAI CAPITAL MANAGEMENTUnchanged3May 15, 2026
CITIGROUP INCNew Position1May 11, 2026
DANSKE BANK A/SUnchanged1May 12, 2026
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTDNew Position1May 11, 2026
UBS Group AGSold Out0May 5, 2026
Stonepine Capital Management, LLCSold Out0May 14, 2026
GEODE CAPITAL MANAGEMENT, LLCSold Out0May 15, 2026
Caitong International Asset Management Co., LtdSold Out0May 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026